Maravai LifeSciences Holdings, Inc. Cost of Revenue
Maravai LifeSciences Holdings, Inc. (MRVI) reported Cost of Revenue of $30.79 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-07
- Maravai LifeSciences Holdings, Inc. cost of revenue for the quarter ending 2026-06-30 was $30.79M, a 22.30% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. cost of revenue for the quarter ending 2026-03-31 was $32.14M, a 17.86% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. cost of revenue for the quarter ending 2025-12-31 was $37.02M, a 0.39% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. cost of revenue for the quarter ending 2025-09-30 was $35.98M, a 2.22% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. cost of revenue for fiscal 2025 was $151.75M, a 0.58% increase from fiscal 2024.
- Maravai LifeSciences Holdings, Inc. cost of revenue for fiscal 2024 was $150.88M, a 1.43% increase from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. cost of revenue for fiscal 2023 was $148.74M, a 11.96% decline from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. cost of revenue for fiscal 2022 was $168.96M, a 20.20% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $30.79M 10-Q · filed 2026-08-07 | $62.93M 10-Q · filed 2026-08-07 | $99.95M derived: sum of 3 quarters · filed 2026-08-07 | $135.93M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2026-03-31 | $32.14M 10-Q · filed 2026-05-08 | $69.16M derived: sum of 2 quarters · filed 2026-05-08 | $105.14M derived: sum of 3 quarters · filed 2026-05-08 | $144.76M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-12-31 | $37.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $73.00M derived: sum of 2 quarters · filed 2026-02-26 | $112.63M derived: sum of 3 quarters · filed 2026-08-07 | $151.75M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $35.98M 10-Q · filed 2025-11-07 | $75.60M derived: sum of 2 quarters · filed 2026-08-07 | $114.73M 10-Q · filed 2025-11-07 | $151.90M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-06-30 | $39.63M 10-Q · filed 2026-08-07 | $78.75M 10-Q · filed 2026-08-07 | $115.92M derived: sum of 3 quarters · filed 2026-08-07 | $152.71M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-03-31 | $39.13M 10-Q · filed 2026-05-08 | $76.29M derived: sum of 2 quarters · filed 2026-05-08 | $113.08M derived: sum of 3 quarters · filed 2026-05-08 | $151.67M derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | $37.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $73.96M derived: sum of 2 quarters · filed 2026-02-26 | $112.54M derived: sum of 3 quarters · filed 2026-02-26 | $150.88M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $36.79M 10-Q · filed 2025-11-07 | $36.83M 10-Q · filed 2024-11-12 | $75.37M derived: sum of 2 quarters · filed 2025-11-07 | $113.71M 10-Q · filed 2025-11-07 | $113.43M 10-Q · filed 2024-11-12 | $148.82M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $38.58M 10-Q · filed 2025-08-11 | $38.27M 10-Q · filed 2024-08-08 | $76.92M 10-Q · filed 2025-08-11 | $76.61M 10-Q · filed 2024-08-08 | $112.03M derived: sum of 3 quarters · filed 2026-02-26 | $148.71M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $38.34M 10-Q · filed 2025-05-12 | $73.44M derived: sum of 2 quarters · filed 2026-02-26 | $110.13M derived: sum of 3 quarters · filed 2026-02-26 | $153.40M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $35.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $71.79M derived: sum of 2 quarters · filed 2026-02-26 | $115.07M derived: sum of 3 quarters · filed 2026-02-26 | $148.74M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $36.69M 10-Q · filed 2024-11-12 | $79.96M derived: sum of 2 quarters · filed 2024-11-12 | $113.64M 10-Q · filed 2024-11-12 | $166.89M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-06-30 | $43.27M 10-Q · filed 2024-08-08 | $76.95M 10-Q · filed 2024-08-08 | $130.20M derived: sum of 3 quarters · filed 2025-03-18 | $168.38M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-03-31 | $33.68M 10-Q · filed 2024-05-09 | $86.93M derived: sum of 2 quarters · filed 2025-03-18 | $125.11M derived: sum of 3 quarters · filed 2025-03-18 | $162.60M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2022-12-31 | $53.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $91.43M derived: sum of 2 quarters · filed 2025-03-18 | $128.93M derived: sum of 3 quarters · filed 2025-03-18 | $168.96M 10-K · filed 2025-03-18 | |||
| 2022-09-30 | $38.18M 10-Q · filed 2023-11-08 | $75.67M derived: sum of 2 quarters · filed 2023-11-08 | $115.70M 10-Q · filed 2023-11-08 | $154.84M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | $37.50M 10-Q · filed 2023-08-08 | $77.53M 10-Q · filed 2023-08-08 | $116.67M derived: sum of 3 quarters · filed 2024-02-29 | $148.89M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | $40.03M 10-Q · filed 2023-05-09 | $79.17M derived: sum of 2 quarters · filed 2024-02-29 | $111.39M derived: sum of 3 quarters · filed 2024-02-29 | $149.20M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $39.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $71.36M derived: sum of 2 quarters · filed 2024-02-29 | $109.17M derived: sum of 3 quarters · filed 2024-02-29 | $140.56M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $32.22M 10-Q · filed 2022-11-04 | $32.05M 10-Q · filed 2021-11-15 | $70.03M derived: sum of 2 quarters · filed 2022-11-04 | $101.42M 10-Q · filed 2022-11-04 | $99.93M 10-Q · filed 2021-11-15 | $124.82M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $37.81M 10-Q · filed 2022-08-05 | $37.51M 10-Q · filed 2021-08-11 | $69.20M 10-Q · filed 2022-08-05 | $67.88M 10-Q · filed 2021-08-11 | $92.60M derived: sum of 3 quarters · filed 2023-02-28 | $112.36M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $31.39M 10-Q · filed 2022-05-06 | $30.37M 10-Q · filed 2021-05-12 | $54.79M derived: sum of 2 quarters · filed 2023-02-28 | $74.55M derived: sum of 3 quarters · filed 2023-02-28 | $95.74M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $23.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $43.16M derived: sum of 2 quarters · filed 2023-02-28 | $64.35M derived: sum of 3 quarters · filed 2023-02-28 | $79.65M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $19.76M 10-Q · filed 2021-11-15 | $40.96M derived: sum of 2 quarters · filed 2021-11-15 | $56.25M 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | $21.20M 10-Q · filed 2021-08-11 | $36.49M 10-Q · filed 2021-08-11 | |||||
| 2020-03-31 | $15.30M 10-Q · filed 2021-05-12 | ||||||
| 2019-12-31 | $66.85M 10-K · filed 2022-03-01 |